Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label follow-up study of TBE vaccine antibody persistence and booster response in children and adolescents
2005-000767-26Phase 4Completed
- Sponsor
- Baxter International Inc.
- Start
- Apr 2005
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Baxter International Inc. Primary endpoints: Seropositivity rate after primary series, Seropositivity rate after booster and 1 more. Started Apr 2005; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2005-000767-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000767-26.